← FDA Drug Approvals (Drugs@FDA)

SEMAGLUTIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX INC · Approved 2026-04-07

Drug application

FDA Application #

ANDA220314

Application type

Abbreviated New Drug Application (Generic)

Brand name

SEMAGLUTIDE

Generic name

Semaglutide

Active ingredients

SEMAGLUTIDE

Dosage form

INJECTION

Route

SOLUTION

Marketing status

None (Tentative Approval)

Sponsor

APOTEX INC

First approval

2026-04-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown